40. Body Mass Index (BMI) and Ovarian Cancer: Impact on Tumor Stage
Anum Jafri1, Sarwat Rizvi2 and Rubar Haider3
ABSTRACT
Objective: To determine the frequency of high body mass index in ovarian cancer and to compare the stage of tumour in patients of ovarian cancers with normal versus high BMI.
Study Design: Descriptive, cross-sectional
Place and Duration of Study: This study was conducted at the Department of Pathology, King Edward Medical University, Lahore from September 2017 to March 2018.
Materials and Methods: One hundred and fourteen patients having ovarian cancer of age 15-55 years were included. Patients having metastatic ovarian carcinoma were excluded. Frequency of high BMI was recorded and two groups (A & B) were formed according to their BMI i.e. body mass index BMI ≥30 kg/m2 and body mass index BMI <30 kg/m2. Tumor stage of these cases was assessed by FIGO staging system.
Results: Mean age was 38.89±10.07 years. Most of the females, i.e. 66 (57.89%) were between 46 to 55 years of age. Mean duration of ovarian cancer was 9.12±3.68 months. Out of the 114 patients, 99 (86.84%) were married and 15 (13.16%) were unmarried. Frequency of high body mass index in ovarian cancer was found in 35 (30.70%) patients, whereas there was normal BMI in 79 (69.30%) patients.
Conclusion: Frequency of high body mass index in ovarian cancer is quite high. No statistically significant difference was noticed in stage of tumour in patients with normal versus high BMI.
Key Words: Ovarian tumours, Body mass index, Stage of tumour, Prognosis
Citation of article: Jafri A, Rizvi S, Haider R. Body Mass Index (BMI) and Ovarian Cancer: Impact on Tumor Stage. Med Forum 2020;31(10):177-180.